IT1138449B - Saggio e vaccino per epatite non-a,non-b - Google Patents

Saggio e vaccino per epatite non-a,non-b

Info

Publication number
IT1138449B
IT1138449B IT22814/81A IT2281481A IT1138449B IT 1138449 B IT1138449 B IT 1138449B IT 22814/81 A IT22814/81 A IT 22814/81A IT 2281481 A IT2281481 A IT 2281481A IT 1138449 B IT1138449 B IT 1138449B
Authority
IT
Italy
Prior art keywords
vaccine
hepatitis
test
Prior art date
Application number
IT22814/81A
Other languages
English (en)
Other versions
IT8122814A0 (it
Inventor
L J Coursaget Pierre
Ch Maupas Philippe
Original Assignee
Baxter Travenol Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Travenol Lab filed Critical Baxter Travenol Lab
Publication of IT8122814A0 publication Critical patent/IT8122814A0/it
Application granted granted Critical
Publication of IT1138449B publication Critical patent/IT1138449B/it

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/82—Hepatitis associated antigens and antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IT22814/81A 1980-07-09 1981-07-08 Saggio e vaccino per epatite non-a,non-b IT1138449B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/167,282 US4464474A (en) 1980-07-09 1980-07-09 Non-A, non-B hepatitis assay and vaccine

Publications (2)

Publication Number Publication Date
IT8122814A0 IT8122814A0 (it) 1981-07-08
IT1138449B true IT1138449B (it) 1986-09-17

Family

ID=22606707

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22814/81A IT1138449B (it) 1980-07-09 1981-07-08 Saggio e vaccino per epatite non-a,non-b

Country Status (4)

Country Link
US (1) US4464474A (it)
EP (1) EP0058676B1 (it)
IT (1) IT1138449B (it)
WO (1) WO1982000205A1 (it)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1172561A (en) * 1981-01-28 1984-08-14 Richard H. Decker Igm detection method
EP0071640B1 (en) * 1981-02-11 1986-06-04 Connaught Laboratories Incorporated Non-a, non-b hepatitis virus
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
US4707439A (en) * 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
US4673634A (en) * 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
US5218099A (en) * 1986-04-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Post-transfusion, non-A, non-B hepatitis virus polynucleotides
EP0261233A4 (en) * 1986-04-01 1988-08-29 Genelabs Inc IMMORTALIZED TISSUE CELLS WITH VIRAL SPECIFICITY.
FR2597606B1 (fr) * 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
US4865966A (en) * 1987-04-17 1989-09-12 New York University Method for detecting antibodies to human immunodeficiency virus
US5447837A (en) * 1987-08-05 1995-09-05 Calypte, Inc. Multi-immunoassay diagnostic system for antigens or antibodies or both
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US6171782B1 (en) * 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
JPH02500880A (ja) * 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
US6861212B1 (en) * 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
WO1990000597A1 (en) * 1988-07-06 1990-01-25 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
IL91371A0 (en) * 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
US5094960A (en) * 1988-10-07 1992-03-10 New York Blood Center, Inc. Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
AU647384B2 (en) * 1989-02-24 1994-03-24 Southwest Foundation For Biomedical Research Non-A, non-B hepatitis hepatocyte cell culture
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
ATE161041T1 (de) * 1989-08-25 1997-12-15 Chiron Corp Verfahren zur hcv-züchtung in zell-linien aus b- oder t-lymphozyten
US7166287B1 (en) 1989-12-18 2007-01-23 Glaxo Wellcome Inc. Viral agent
GR1001261B (el) * 1989-12-18 1993-06-30 Wellcome Found Ιϊκός παράγων.
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
US5747239A (en) * 1990-02-16 1998-05-05 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and preventions thereof as vaccines
KR940000755B1 (ko) * 1990-02-16 1994-01-29 유나이티드 바이오메디칼 인코오포레이티드 Hcv에 대한 항체 검출, hcv 감염의 진단 및 백신으로서의 그 예방에 특히 적합한 합성 펩티드
EP0447984A1 (en) * 1990-03-20 1991-09-25 Abbott Laboratories Hyperimmune globulin against hepatitis C virus and method for making same
AU7672991A (en) * 1990-04-03 1991-10-30 Southwest Foundation For Biomedical Research Purified hcv and hcv proteins and peptides
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
DE69132332T2 (de) * 1990-04-06 2000-11-30 Genelabs Technologies, Inc. Hepatitis c-virus-epitope
GB2245123B (en) * 1990-06-13 1994-06-29 Sony Corp Video signal dropout compensation
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
CA2075521C (en) * 1992-05-05 1995-11-28 Kuniaki Koyama Stabilized live vaccine
GB9304399D0 (en) * 1993-03-04 1993-04-21 Smithkline Beecham Biolog Novel process
WO1994025064A1 (en) * 1993-05-04 1994-11-10 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES Hepatitis c virus cell propagation and related methods
US5739019A (en) * 1994-08-08 1998-04-14 Walker; Harrell L. Method of isolating and propagating microorganisms and viruses
US6815160B1 (en) * 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
ES2279766T3 (es) * 1999-07-28 2007-09-01 Novartis Vaccines And Diagnostics, Inc. Sistemas de deteccion por inmunoensayos del antigeno viral de hepatitis c.
WO2009080719A1 (en) * 2007-12-21 2009-07-02 Glaxosmithkline Biologicals S.A. Vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1105178A (en) * 1965-11-17 1968-03-06 Andreas Lembke Improvements in or relating to antigens suitable for the diagnosis of hepatitis
US3887697A (en) * 1971-08-09 1975-06-03 Us Health Hemagglutination method for australia antigen and antibody thereto
US4013411A (en) * 1971-09-01 1977-03-22 Villanova University Method for detecting hepatitis associated antigen
US4012494A (en) * 1971-12-21 1977-03-15 Abbott Laboratories Direct radioimmunoassay for antigens and their antibodies
DE2523209A1 (de) * 1975-05-26 1976-12-16 Noeller Hans Guenter Dr Med Elektrooptische, substanzschonende erfassung von nicht zellgebundenen immunostoffen
US4157280A (en) * 1975-09-29 1979-06-05 Cordis Corporation Test set for detecting the presence of antigens associated with hepatitis
US4100267A (en) * 1975-10-01 1978-07-11 Ortho Diagnostics Inc. Method of detecting hepatitis B core antigen and antibody
US4234564A (en) * 1977-12-19 1980-11-18 Merck & Co., Inc. Hepatitis B core antigen composition
US4189464A (en) * 1978-05-05 1980-02-19 Institute For Cancer Research Hepatitis B testing reagent and method
US4202665A (en) * 1978-11-06 1980-05-13 Albert Einstein College Of Medicine Of Yeshiva University A Division Of Yeshiva University Detection of hepatitis B surface antigen
US4356164A (en) * 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen

Also Published As

Publication number Publication date
WO1982000205A1 (en) 1982-01-21
IT8122814A0 (it) 1981-07-08
EP0058676A4 (en) 1982-11-25
US4464474A (en) 1984-08-07
EP0058676B1 (en) 1986-10-08
EP0058676A1 (en) 1982-09-01

Similar Documents

Publication Publication Date Title
IT1138449B (it) Saggio e vaccino per epatite non-a,non-b
BR9206131A (pt) Hepatite C: diagnóstico e vacinas
DE3886363D1 (de) NANBV-Diagnostika und Vakzine.
FI894580A7 (fi) Non-A, non-B-hepatitisvirusantigeenipeptidi
EP0029063A4 (en) DETERMINATION OF THE NON-A, NON-B HEPATITIS ANTIGENS.
EP0423239A4 (en) Post-transfusion, non-a, non-b hepatitis virus and antigens
FI942369L (fi) Hepatitis-C-virustesti
GB2108527B (en) Non-a non-b hepatitis virus
DK163210C (da) Fremgangsmaade til inaktivering af et lipidvirus i form af hepatitis b virus og/eller non-a, non-b hepatitis virus
DK155915C (da) Fremgangsmaade til fremstilling af pertussis-toksoid til anvendelse i vacciner
FR2344629A1 (fr) Procede pour la purification et l'isolement de virus de l'hepatite utilisable pour la preparation d'un vaccin
IT7940053A0 (it) Metodo e dispositivo perfezionati per pulire le bottiglie
ITMI910754A0 (it) Procedimento e disposizione per condensare sostanze vaporose
AU504454B2 (en) Hepatitis b antigen and vaccine
IT8323350A0 (it) Procedimento e dispositivo per depurare gas.
EG13435A (en) High molecular weight meningococal group c.vaccine and method for preparation thereof
DK52290D0 (da) Fremgangsmaade til rensning af fisk, samt apparat til udoevelse af fremgangsmaaden
ZA761346B (en) Vaccine for active immunization containing hepatitis b surface antigen and associated antigen
DE3377401D1 (de) Non-a, non-b hepatitis antigen
DK0614979T3 (da) Svinepestvirusvaccine og diagnostik
ZA803845B (en) Polyvalent virus vaccines
DE69032787D1 (de) Mutantes pseudorabiesvirus und dasselbe enthaltende vakzine
EP0068465A3 (en) Non-a, non-b hepatitis-associated antibody or antibody conjugate, the use thereof and detection reagent
IL73973A0 (en) Detection of non-a,non-b hepatitis
DK353789D0 (da) Nanbv-diagnostika og -vacciner

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19960726